COVID-19 Updates: Learn the latest on coronavirus in our community

VaccinesVisitor GuidelinesTestingCOVID-19 Info

Condition | Cancer

ALLIANCE A081105

  • IRB Number: ALLIANCE A081105
  • Contact Name: Rachel O'Loughlin, RN BSN
  • Status: Enrolling
  • Phone: (585) 747-4555
  • Lead Researcher: Mehul Patel, MD

Description

Randomized Study of Erlotinib vs Observation In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

https://clinicaltrials.gov/ct2/show/NCT02193282

Related Clinical Trials

MM Registry

Multiple Myeloma Registry - Observational Registry Collecting Data on Patients Diagnosed with Multiple Myeloma
View Clinical Trial

ECOG ACRIN E4512

A Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
View Clinical Trial

Alliance A011502

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial 
View Clinical Trial
View All Clinical Trials